{"name":"Shanghai Cell Therapy Group Co.,Ltd","slug":"shanghai-cell-therapy-group-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fast CAR T cells","genericName":"Fast CAR T cells","slug":"fast-car-t-cells","indication":"Other","status":"phase_1"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"NMN","genericName":"NMN","slug":"nmn","indication":"Age-related metabolic decline","status":"marketed"}]}],"pipeline":[{"name":"Fast CAR T cells","genericName":"Fast CAR T cells","slug":"fast-car-t-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"NMN","genericName":"NMN","slug":"nmn","phase":"marketed","mechanism":"NMN (nicotinamide mononucleotide) replenishes cellular NAD+ levels to support mitochondrial function and energy metabolism.","indications":["Age-related metabolic decline","Mitochondrial dysfunction support"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNTlVHbXpaNFRaTGxocDFLamFvZUFlMzMwMTBTM1djcFNaZkRzX2kwVnZ0Uk5pQzFsMDJOQWVBQXRJby1vQS12b092YndtNWxaZm5ROGhSTzk3V19EeDYwRzlUTkl5T1FuRTZTZlBiTWtpUlBBMkEzVXBtYWh2UVpFczFBWDA4QkFGcV9tRGg4MmQ0X0dwUENodm9EdjZtR2FraUo5ZE14WFJoZXlWb3pkaDNXUEdFODBPcXlKWWdZd0gwNEk1QnpoUV82NnJFLS10Q2EyaEtzbE01cGNSbGdJNg?oc=5","date":"2026-03-19","type":"pipeline","source":"Reuters","summary":"AstraZeneca to build cell therapy base, innovation centre in Shanghai - Reuters","headline":"AstraZeneca to build cell therapy base, innovation centre in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOS2pKb2s1MDRUWk91ejM5dVJYb2hjemlKSTdPX0had3JOeEZZanZmRFpfZVJGR0Vibjg2Y3dyZzdwZk10ODJwcUtOVWJrMXJOZ3hhYnVuS0RZTEdxZzR2LUVVVVhORnpNOFRSMzBmcXVnbVdrM1JPeTRaSWJMeURWVEp5Z0F2MWozTjVHVWloVUhMNEZsQUQxUE5rRnZiYi0xRHZlSG5vV2YwOW9uN3VwcWpWV1FNQUZlNmhMMEpzbGxzaUdiUHQ1QmVKMWtkeDE3SXoxdTFsdzcxT1hQcWttMXRXeU9iQQ?oc=5","date":"2026-01-15","type":"deal","source":"BioSpectrum Asia","summary":"AdCella and Shanghai Cell Therapy Group launch global collaboration on groundbreaking cancer therapy - BioSpectrum Asia","headline":"AdCella and Shanghai Cell Therapy Group launch global collaboration on groundbreaking cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNSFFvQXpJSHdtOGVZZDhTMlE1aGlGZnN3c3hOX1N4OUlHOWpxUVBacUhZQ1ZyblREc0NMR2tobjJFaWdJTE5YTHZFa2t5bldpdmJTN25QNWFMR1ExQWtaVjJOaFF6NVVFLTc2VnlLUHNFTFlZUHhLWUpySWlfS2p2dUcyZ3p0VXcwdkpSN2NmV002UlBHYzNjT2tHb25tYmdTT1BsaGk4OUd0RldJV1hndC1FSW9lb3JxSzlOY3FfUXFabVAyYWtVcFVSYVVpNkc0N1dvdXZvOEN2ck9uVFdvTDhqMjVWOUhHZ3c1Y0F2Q3d5ZW9hd1VmN29n?oc=5","date":"2026-01-13","type":"pipeline","source":"South China Morning Post","summary":"Biotech disruptor pushes cancer-targeting cell and gene therapies beyond boundaries - South China Morning Post","headline":"Biotech disruptor pushes cancer-targeting cell and gene therapies beyond boundaries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOYjBrbWRPOGFHcEU0MS03SWktZTd0T3ktcDgzdi1zY2pEcnJuVk52OXpYVHMxRjV6OVY4MUJFVm9pNVd0YTMwMFY5dm1XMVdtNG5SS0JVQ0lMck1tSkZ6U3JDVTNNQVZmYTU3Ni0wTkVzQi1rVDhCbE1jUEZZMmhfZ0gwSzh0aDhPeUtGcS1NQnl5RUZkdkdkX2xOdW9lNEF0SElkN09Hb09OWERGVVVlQnd0Ym5jeEk?oc=5","date":"2026-01-02","type":"deal","source":"PharmaDispatch","summary":"AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy - PharmaDispatch","headline":"AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPYURpUDI0NUhEckszNlBmVmVKZ1dRRFczXzVmSHdVNnIybDlYMm5uNmNpdEx2bTBWWXpmVE9SNEZzZEtRMVJ1X2w2WHRUM0hVQ3VCeng5Z1BqSWNxUjJ5QkQzd0trblJjamRWUFZUQTBvRmlMMHJ1M3pud2ZkMlRxaEhB?oc=5","date":"2025-09-17","type":"deal","source":"China Daily - Global Edition","summary":"Merck aims to partner with pharma innovators - China Daily - Global Edition","headline":"Merck aims to partner with pharma innovators - China Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBseXQxVFZRZE5DTGQxSmlBUExxd1RLLWx2czl1MmtONVFjVk5CZ01VbmlBd041WHZacWduV0pqQ2pVZFllRm9HZXZMaHJFR29tQlFmbTJWWU1aaEc5c21J?oc=5","date":"2025-08-14","type":"trial","source":"Nature","summary":"Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study - Nature","headline":"Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2V0VElQcHUtUGpnSl9rcF9NSXRTNURjclVVa2VSZ0dnM2ZJNzU5WFViSHpmaTU1SjViakQteFR2Q1ZjSFNMY2JKWENkcDY3UmtnMWFUR2VEenNzaFltUEctaFdHOXJpQl92VHc4WG0xS1oya2JVTm9PN0twUE9Nd25CLVpXeS1WZVhkV0tYS1gtUFNPS1NGODI5OEROS25xcnJZV3B3?oc=5","date":"2025-08-12","type":"trial","source":"BioWorld News","summary":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M - BioWorld News","headline":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZUEtbzJjSUR4TWtfdHpVbnRhd0xkNEJwdFJ5M29Oc2dSSmFMckwyVl9FeTF4c00zZmU3Mkd1MGJwcnpMMzhtczhTLXU4Q0VHNEk2azc2X3FFdExrb2ZySUtqaURiY2taLWhOc1I5M19UQnlVOXpzNExQaG1aVGRJV2ZOVTJ5WHM2NV9MM01RSkc4NUE?oc=5","date":"2024-09-19","type":"pipeline","source":"Fierce Pharma","summary":"Gilead's Kite exits China cell therapy joint venture with Fosun Pharma - Fierce Pharma","headline":"Gilead's Kite exits China cell therapy joint venture with Fosun Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxNdXdiNVFWazBkRVBpT1gzVEYweHBVM01nQS0yTmxPaWNtdzMtVmxSU0tVRjExNDBoejNlRTJVQzJRaW1HUXZqOE9ySERaWVJMSHAxN0o1dkdWSFJPdEpaMy02UGMxSklONWtvMmYtY2pLQ0dGcW9tbHNQOUtLTEJ4NDYwRUhpdkxQOHZSX1g3OVR5RGtiN1ZzNUN0UVJmUHNYVVhhUUFjV1FoUXFHU2JqQXR6SGFEcnFUdjVXdWY0a1RpZVB4NU5FVmVtamtvZHFI?oc=5","date":"2023-07-18","type":"regulatory","source":"prnewswire.com","summary":"Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication - prnewswire.com","headline":"Yikaida CAR-T Cell Therapy Approved as a Second-line Therapy for New Indication","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2023-05-31","type":"trial","source":"GlobeNewswire","summary":"B-Cell Lymphoma Clinical Trial Pipeline Insights: - GlobeNewswire","headline":"B-Cell Lymphoma Clinical Trial Pipeline Insights:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxNNWVJVWtTWHVpUUQyZm5GMllxVXdyRXBKV2J6R2dPQWN2cXFIQ19jdzRGYmFLTk85U3h5dzJ1RFk5RTVydElFYXhRNHVGZTZCZ3ZsNXFQQ2lFVUxtS0lvcWFUeEJDMmtSMEdWakRCVm1qMDF0akxiMGJjRHdBMUdTZS1LdDZIMDQ3SmRyeHhlZ0JQUUlieHBmdHZicVVmMm9zbmtSUnYzZXVqeFUxckIzdVY5N2hwaEk1dzVCRllIdXhJM09ZMDNJLW1ZWWRha1ByTEZPdHFrdWhwVmdwRmZ4ZGxDSURZTlBMejJzbENSN3Q?oc=5","date":"2023-04-25","type":"pipeline","source":"BioPharma APAC","summary":"OBiO Technology Launches New Super Factory in Shanghai with 29 GMP-Grade Production Lines for Gene and Cell Therapy - BioPharma APAC","headline":"OBiO Technology Launches New Super Factory in Shanghai with 29 GMP-Grade Production Lines for Gene and Cell Therapy","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}